LG
CRL icon

Leuthold Group’s Charles River Laboratories CRL Stock Holding History

Leuthold Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,374
Closed -$518K – 196
2021
Q4 		$518K Sell
1,374
-16
-1% -$6.22K 0.06% 140
2021
Q3 		$574K Hold
1,390
– – 0.07% 129
2021
Q2 		$514K Sell
1,390
-38
-3% -$12.7K 0.06% 135
2021
Q1 		$414K Sell
1,428
-35
-2% -$9.73K 0.05% 137
2020
Q4 		$366K Sell
1,463
-59
-4% -$14.1K 0.05% 141
2020
Q3 		$345K Sell
1,522
-43
-3% -$8.92K 0.05% 142
2020
Q2 		$273K Sell
1,565
-22
-1% -$3.51K 0.04% 138
2020
Q1 		$200K Buy
+1,587
New +$238K 0.04% 141
2018
Q1 		– Sell
-54,129
Closed -$5.92M – 201
2017
Q4 		$5.92M Buy
+54,129
New +$5.89M 0.59% 60

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Leuthold Group's CRL Position: Q1 2022 in Review

Leuthold Group sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 1,374 shares — an estimated $518K sold.

Leuthold Group first reported a position in CRL in Q4 2017 and held it in 9 quarters. The position peaked at $5.92M in Q4 2017. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • Leuthold Group reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • Leuthold Group sold 1,374 Charles River Laboratories shares in Q1 2022, an estimated $518K.
  • Leuthold Group first reported a position in Charles River Laboratories in Q4 2017 and held it in 9 quarters.
  • Leuthold Group's Charles River Laboratories position peaked at $5.92M in Q4 2017.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on Leuthold Group's 13F filing for Q1 2022, filed 4 May 2022.